289 related articles for article (PubMed ID: 27256305)
1. Trabeculectomy with ologen in secondary glaucomas following failed trabeculectomy with MMC: comparative study.
El-Saied HM; Abdelhakim MA
Eye (Lond); 2016 Aug; 30(8):1126-34. PubMed ID: 27256305
[TBL] [Abstract][Full Text] [Related]
2. Trabeculectomy with Ologen versus Mitomycin C in Juvenile Open-Angle Glaucoma: A 1-Year Study.
El-Sayyad F; El-Saied HMA; Abdelhakim MASE
Ophthalmic Res; 2017; 57(4):230-238. PubMed ID: 28291960
[TBL] [Abstract][Full Text] [Related]
3. Biodegradable collagen matrix implant versus mitomycin-C in trabeculectomy: five-year follow-up.
Cillino S; Casuccio A; Di Pace F; Cagini C; Ferraro LL; Cillino G
BMC Ophthalmol; 2016 Mar; 16():24. PubMed ID: 26946419
[TBL] [Abstract][Full Text] [Related]
4. Trabeculectomy with combined use of subconjunctival collagen implant and low-dose mitomycin C.
Dada T; Kusumesh R; Bali SJ; Sharma S; Sobti A; Arora V; Panda A
J Glaucoma; 2013; 22(8):659-62. PubMed ID: 23059478
[TBL] [Abstract][Full Text] [Related]
5. Prospective Randomized Trial Comparing Mitomycin C Combined with Ologen Implant versus Mitomycin C Alone as Adjuvants in Trabeculectomy.
Sen M; Midha N; Sidhu T; Angmo D; Sihota R; Dada T
Ophthalmol Glaucoma; 2018; 1(2):88-98. PubMed ID: 32677614
[TBL] [Abstract][Full Text] [Related]
6. Using a collagen matrix implant (Ologen) versus mitomycin-C as a wound healing modulator in trabeculectomy with the Ex-PRESS mini glaucoma device: a 12-month retrospective review.
Johnson MS; Sarkisian SR
J Glaucoma; 2014 Dec; 23(9):649-52. PubMed ID: 24240882
[TBL] [Abstract][Full Text] [Related]
7. Biodegradable collagen matrix implant vs mitomycin-C as an adjuvant in trabeculectomy: a 24-month, randomized clinical trial.
Cillino S; Di Pace F; Cillino G; Casuccio A
Eye (Lond); 2011 Dec; 25(12):1598-606. PubMed ID: 21921953
[TBL] [Abstract][Full Text] [Related]
8. Evaluating the long-term efficacy of short-duration 0.1 mg/ml and 0.2 mg/ml MMC in primary trabeculectomy for primary adult glaucoma.
Sihota R; Angmo D; Chandra A; Gupta V; Sharma A; Pandey RM
Graefes Arch Clin Exp Ophthalmol; 2015 Jul; 253(7):1153-9. PubMed ID: 25940554
[TBL] [Abstract][Full Text] [Related]
9. Tube Shunt Revision With Excision of Fibrotic Capsule Using Mitomycin C With and Without Ologen-a Collagen Matrix Implant: A 3-Year Follow-up Study.
Salimi A; Kovalyuk N; Harasymowycz PJ
J Glaucoma; 2019 Nov; 28(11):989-996. PubMed ID: 31567908
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of Bevacizumab Compared to Mitomycin C Modulated Trabeculectomy in Primary Open Angle Glaucoma: A One-Year Prospective Randomized Controlled Study.
Kaushik J; Parihar JK; Jain VK; Gupta S; Nath P; Durgapal P; Ram J
Curr Eye Res; 2017 Feb; 42(2):217-224. PubMed ID: 27269279
[TBL] [Abstract][Full Text] [Related]
11. Ologen implant versus mitomycin C in combined trabeculectomy and phacoemulsification.
Paul C; Divya J; Kamal R; Paul A
Indian J Ophthalmol; 2022 Apr; 70(4):1248-1252. PubMed ID: 35326026
[TBL] [Abstract][Full Text] [Related]
12. Trabeculectomy with subconjunctival collagen implant in Indian eyes: Long-term results.
Singh K; Bhattacharyya M; Mutreja A; Dangda S
Indian J Ophthalmol; 2018 Oct; 66(10):1429-1434. PubMed ID: 30249827
[TBL] [Abstract][Full Text] [Related]
13. Phacotrabeculectomy using collagen matrix implant (Ologen
Wlaź A; Wilkos-Kuc A; Rozegnał-Madej A; Żarnowski T
Acta Ophthalmol; 2019 Sep; 97(6):e817-e826. PubMed ID: 30924600
[TBL] [Abstract][Full Text] [Related]
14. A Retrospective Comparison of Primary Baerveldt Implantation versus Trabeculectomy with Mitomycin C.
Panarelli JF; Banitt MR; Gedde SJ; Shi W; Schiffman JC; Feuer WJ
Ophthalmology; 2016 Apr; 123(4):789-95. PubMed ID: 26746596
[TBL] [Abstract][Full Text] [Related]
15. Outcomes of Trabeculectomy and Phacotrabeculectomy With Collagen Matrix Implant (Ologen) and Low-dose Mitomycin C: 2-Year Follow-up.
Castejón MA; Teus MA; Bolivar G; Paz-Moreno-Arrones J; Castaño B
J Glaucoma; 2018 Jan; 27(1):50-54. PubMed ID: 29117004
[TBL] [Abstract][Full Text] [Related]
16. Simultaneous use of amniotic membrane and Mitomycin C in trabeculectomy for primary glaucoma.
Yadava U; Jaisingh K; Dangda S; Thacker P; Singh K; Goel Y
Indian J Ophthalmol; 2017 Nov; 65(11):1151-1155. PubMed ID: 29133641
[TBL] [Abstract][Full Text] [Related]
17. Comparison of outcomes of trabeculectomy with mitomycin C vs. ologen implant in primary glaucoma.
Senthil S; Rao HL; Babu JG; Mandal AK; Garudadri CS
Indian J Ophthalmol; 2013 Jul; 61(7):338-42. PubMed ID: 23571259
[TBL] [Abstract][Full Text] [Related]
18. Role of subconjunctival bevacizumab as an adjuvant to primary trabeculectomy: a prospective randomized comparative 1-year follow-up study.
Akkan JU; Cilsim S
J Glaucoma; 2015 Jan; 24(1):1-8. PubMed ID: 23661044
[TBL] [Abstract][Full Text] [Related]
19. Subscleral trabeculectomy with mitomycin-C versus ologen for treatment of glaucoma.
Marey HM; Mandour SS; Ellakwa AF
J Ocul Pharmacol Ther; 2013 Apr; 29(3):330-4. PubMed ID: 23113645
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and Safety of Ologen Implant Versus Mitomycin C in Primary Trabeculectomy: A Meta-analysis of Randomized Clinical Trials.
Ji Q; Qi B; Liu L; Guo X; Zhong J
J Glaucoma; 2015; 24(5):e88-94. PubMed ID: 25264995
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]